The role of gut microbiome disruption in the development of metabolic dysfunction-associated kidney disease
{{output}}
Metabolic dysfunction-associated kidney disease (MDAKD) is increasingly recognised as a major clinical consequence of the global rise in obesity, type 2 diabetes, hypertension, and cardiovascular disease. Accumulating evidence suggests that the gut microbiota ... ...
